GGrantIndex
← Leaderboards

Eric A. Johnson

University Of Wisconsin Madison

Google Scholar ↗PubMed ↗ORCID ↗
$9,478,846
Attributed
$16,629,610
Total exposure
11
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.2M · FY2005–20
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20

Funding mix

By agency

NIH$16,629,610 · 11

By mechanism

R01$13,537,691 · 5
R21$1,347,252 · 3
U54$1,180,568 · 2
R56$564,099 · 1

Top collaborators

Most similar at University Of Wisconsin Madison

Same institution · by research overlap

Others in their field

Top investigators on “Toxin”

Research focus

ToxinLaboratoriesSerotypingBontoxilysinNeuronsBaseCellsRecombinantsBotulinum Toxin Type ABotulismIntoxicationIn VivoProteinsPropertyLightToxic EffectTraffickingProductionVaccinesIn VitroResponseVariantEngineeringBotulinum Toxin Type B

Grant awards (32)

Vaccines Against Botulism$716,173
R01 · FY2020 · AI
Characteristics of Botulinum Neurotoxins that determine potency$651,728
R01 · FY2020 · AI · contact PI
Characteristics of Botulinum Neurotoxins that determine potency$658,892
R01 · FY2019 · AI · contact PI
Vaccines Against Botulism$578,347
R01 · FY2019 · AI
Vaccines Against Botulism$585,553
R01 · FY2018 · AI
Vaccines Against Botulism$593,592
R01 · FY2017 · AI
Characterization of botulinum neurotoxin A subtypes$564,099
R56 · FY2017 · AI · contact PI
Novel therapeutic approaches to treatment of botulinum neurotoxin poisoning$1,238,429
R01 · FY2016 · AI
Vaccines Against Botulism$600,014
R01 · FY2016 · AI
Characterization of Botulinum Neurotoxin A Subtypes$389,033
R01 · FY2016 · AI · contact PI
Novel therapeutic approaches to treatment of botulinum neurotoxin poisoning$1,238,429
R01 · FY2015 · AI
Characterization of Botulinum Neurotoxin A Subtypes$393,005
R01 · FY2015 · AI · contact PI
Vaccines Against Botulism$342,970
R01 · FY2015 · AI
Construction and Analysis of BoNT derivatives as Pain Specific Inhibitors$230,996
R21 · FY2015 · AI
Characterization of Botulinum Neurotoxin A Subtypes$394,832
R01 · FY2014 · AI · contact PI
Construction and Analysis of BoNT derivatives as Pain Specific Inhibitors$205,506
R21 · FY2014 · AI
Novel therapeutic approaches to treatment of botulinum neurotoxin poisoning$1,164,124
R01 · FY2013 · AI
Characterization of Botulinum Neurotoxin A Subtypes$408,539
R01 · FY2013 · AI · contact PI
Novel therapeutic approaches to treatment of botulinum neurotoxin poisoning$403,485
R01 · FY2013 · AI
Novel therapeutic approaches to treatment of botulinum neurotoxin poisoning$1,238,429
R01 · FY2012 · AI
Characterization of Botulinum Neurotoxin A Subtypes$429,052
R01 · FY2012 · AI · contact PI
Novel therapeutic approaches to treatment of botulinum neurotoxin poisoning$1,381,473
R01 · FY2011 · AI
Development of a Highly Sensitive Cell-Based Assay for Botulinum Neurotoxin$222,750
R21 · FY2010 · AI · contact PI
Development of a Highly Sensitive Cell-Based Assay for Botulinum Neurotoxin$185,625
R21 · FY2009 · AI · contact PI
Characterization of Botulinum Toxin Subtypes - Genetics of Types$261,926
U54 · FY2008 · AI · contact PI
Clostridium botulinum and neurotoxin core facility$167,362
U54 · FY2008 · AI · contact PI
Characterization of Botulinum Toxin Subtypes - Genetics of Types$253,727
U54 · FY2007 · AI · contact PI
Characterization of Botulinum Toxin Subtypes - Genetics of Types$257,371
U54 · FY2006 · AI · contact PI
Development of Genetic Tools for Clostridium botulinum$245,500
R21 · FY2005 · AI
Characterization of Botulinum Toxin Subtypes - Genetics of Types$240,182
U54 · FY2005 · AI
Development of Genetic Tools for Clostridium botulinum$256,875
R21 · FY2004 · AI
REGULATION OF BOTULINUM NEUROTOXIN$131,592
R01 · FY2000 · AI